CSBR:NASDAQ
Champions Oncology Inc
US$ ४.७६
arrow_downward
-१.४५%(-०.०७०) 1D
नोभेम्बर ५, १६:००:०० GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$ ४.७६
High
US$ ४.८५
Low
US$ ४.७२
Mkt. cap
६.६३ करोड
Avg. vol.
९.२४ हजार
Volume
९.११ हजार
52-wk high
US$ ८.३१
52-wk low
US$ ४.६३
EPS
-US$ ०.०८
Beta
०.४७
Shares outstanding
१.३९ करोड
No. of employees
२१७
Open
US$ ४.७६
High
US$ ४.८५
Low
US$ ४.७२
Mkt. cap
६.६३ करोड
Avg. vol.
९.२४ हजार
Volume
९.११ हजार
52-wk high
US$ ८.३१
52-wk low
US$ ४.६३
EPS
-US$ ०.०८
Beta
०.४७
Shares outstanding
१.३९ करोड
No. of employees
२१७
News stories
From web sources and news partners
WSJ
·
५७ मिनेट पहिले
Your House vs. the Stock Market: Which Has Been a Better Investment?
USA Today
·
५४ मिनेट पहिले
Mobilicom (NASDAQ: MOB) to Showcase SwarmiX Communications Technology at UVID DroneTech 2026
Investing.com
·
४ मिनेट पहिले
S&P 500 dip-buying levels: key support zones to watch
The Washington Post
·
५५ मिनेट पहिले
Stocks tumble, erasing post-midterm gains as markets weigh future of AI build-out
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees२१७
Founded२००७
HeadquartersHackensack, न्यु जर्सी, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitechampionsoncology.com